Top Technologies in Health and Wellness, 2017
Top Technologies in Health and Wellness, 2017
Top technology trends that are likely to have an impact in 2017
28-Apr-2017
Global
Description
This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Editing and Predictive Biomarkers.
Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.
Table of Contents
1.1 Research Scope and Index
1.2 Selection Methodology
1.3 Assessment of Top Technologies: 2015 and 2016
1.4 Global Health & Wellness Trends Across 2017
1.5 Key Findings
1.5 Key Findings (continued)
2.1 Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future
2.2 Big Pharma Likely to Lead Global Precision Oncology Innovations
2.3 Precision Oncology Likely to Witness Continued Growth in IP and Funding Activities
2.4 Precision Medicine Innovations Likely to Transform Global Cancer Management Landscape
3.1 Next-generation Sequencing Technologies Likely to Disrupt Existing Molecular Diagnostic Platforms
3.2 Emerging Molecular Diagnostic Platforms Present a Growing Market Opportunity
3.3 US Leads the Patent and Funding Landscape for MDx Innovations
3.4 Emerging NGS Platforms Likely to Transform Global MDx Landscape
4.1 Predictive Biomarker Technologies Lead Personalized Medicine Platforms
4.2 US Leads the IP Landscape for Predictive Biomarkers
4.3 Personalized Genomics Start-ups Lead the Venture Landscape
4.4 Genomic Tests Likely to Lead Biomarker Enabling Platforms
5.1 Liquid Biopsy Profiling Platforms Likely to Disrupt Tumor Tissue Biopsy Techniques
5.2 Tumor Profiling Market Poised for Continued Growth
5.3 US Leads the IP Landscape for Tumor Profiling
5.4 Liquid Biopsy Startups Dominate the Venture Landscape
5.5 Liquid Biopsy Techniques likely to Transform Early Tumor Screening
6.1 Stem Cell Therapy is Expected to Address the Most Crucial Medical Challenges
6.2 The Stem Cell Therapy Field is Very Active In Terms Of New Companies Significantly Impacting the Market by 2021
6.3 Stem Cells Paving the Way for Precision Medicine Through an Unprecedented Technology Synergy
6.4 New Japanese Regulatory Framework Impacting Healthcare Globally
7.1 Gene Editing Techniques Paving the way for Disease Research and Novel Therapeutics
7.2 CRISPR-Cas9 Gene Editing Technology Will Significantly Impact the Market by 2021
7.3 Gene Editing Techniques Paving the Way for Precision Medicine
7.4 North America and Europe are Dominating the Gene Editing Market
8.1 Microbiomics Impacts Key Consumer Benefit Areas Such as Skin and Gut Health
8.2 Diversity of Market Potential Provides Multiple Opportunities for Rapid Growth
8.3 US-based Inventors are Leading in Microbiome-Focused R&D
8.4 Skincare, GI, and Immunity are Key Consumer Benefit Areas for Microbiome-Focused Products
9.1 Immunotherapy Is Pushing the Barriers of Standard Cancer Therapy
9.2 Replacing Chemotherapy as First-line Treatment Option Increases Revenue Potential of Immunotherapies
9.3 US-Based Inventors are Leading In Immune-Focused R&D
9.4 Immuno-oncology Is the Largest Application Segment Present Under Immunotherapy
10.1 Biobetters: A Whole New Generation of Biosimilars
10.2 Greater Adoption of Biosimilars Directly Impact by the Degree of Pharmaceutical Involvement
10.3 Patenting across Biosimilars Largely Happens around Process and Production Techniques
10.4 Oncology is Currently the Disease Area Getting Impacted the Most by Biosimilars
11.1 Tissue Engineering Has Become a Promising Field among the Foremost Innovative Areas of Medical Care Today
11.2 3D Bioprinting Technology is Expected to Have Greatest Impact in the Market by 2025
11.3 Additional Commercial Opportunities in Assembly, Manufacturing, and Drug Delivery Sectors
11.4 Regional Differentiation Approaches Make the Tissue Engineering Sphere Highly Dynamic
Legal Disclaimer
12.1 The Frost & Sullivan Story
12.2 Value Proposition: Future of Your Company & Career
12.3 Global Perspective
12.4 Industry Convergence
12.5 360º Research Perspective
12.6 Implementation Excellence
12.7 Our Blue Ocean Strategy
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Madhumitha Rangesa |
WIP Number | D7C9-01-00-00-00 |
Is Prebook | No |